59
76
Levin N W, Hulbert – Shearon T E, Strawderman R L, Port F K: Which causes of
death are related to hyperphosphatemia in haemodialysis (HD) patients? J Am Soc
Nephrol. 1998; 9: 603A.
77
Jono S, McKee M, Shioi A, Nishizawa Y, Mori K, Morii H et al. Phosphate regulation
of vascular smooth muscle cell calcification. Circ Res. 2000; 87: e10-e17.
78
Marchais S J, Metivier F, Guerin A P, London G M: Association of
hyperphosphatemia with haemodinamic disturbances in end – stage renal disease.
Nephrol Dial Transplant. 1999; 14: 2178-2183.
79
Amann K, Wiest G, Zimmer G, Gretz N, Ritz E, Mall G: Reduced capillary density in
the myocardium of uremic rats: A stereological study. Kidney Int. 1992; 42: 1079-1085.
80
Amann K, Törnig J, Fletchenmacher C H, Nabokov A, Mall G, Ritz E: Blood –
pressure- independent wall thickening of intra- myocardial arterioles in experimental
uraemia: Evidence for a permissive action of PTH. Nephrol Dial Transplant. 1995;10:
2043-2048.
81
Törnig J, Kugel B, El- Shakmak A. Effects of high and low phosphate diet on
cardiovascular changes in subtotally nephrectomized rats. Kidney Blood Press Res.
1998; 21: 104A.
82
Foley R N, Parfrey P S, Harnett J D, Kent G M, Hu L, O’Dea R et al: Hypocalcemia,
morbidity, and mortality in end – stage renal disease. Am J Neprol. 1996; 16: 386-393.
83
Schwaiz U, Buzello M, Ritz E, Stein G, Raabe G, Wiest G et al: Morphology of
coronary atherosclerotic lesions in patients with end – stage renal failure. Nephrol Dial
Transplant. 2000; 15: 218-223.
84
Rostand S G, Drüeke T B. Parathyroid hormone, vitamin D, and cardiovascular
disease in chronic renal failure. Kidney Int. 1999; 56: 383-392.
85
Andress, Dennis L: New therapies raise new issues for lowering parathyroid hormone
levels in uremic patients. Semin Dial. 1999; 12: 282-284.
86
Berdud I, Martin-Malo A, Almaden Y, Aljama P, Rodriguez M, Felsenfeld AJ.: The
PTH-Calcium relationship during a range infused PTH doses in the
parathyroidectomized rat. Calcif Tissue Int. 1998; 62:457-461.